36
Development of optimally controlled drug release device using multi-layered electro-active nano- polymers Project Guide: Prof. Kajari Kargupta Dept. Of Chemical Engineering Jadavpur University Dr. Saptarshi Majumdar Dept. Of Chemical Engineering Indian Institute Of Technology Hyderabad

Development of optimally controlled drug release device using

Embed Size (px)

Citation preview

Page 1: Development of optimally controlled drug release device using

Development of optimally controlled drug release

device using multi-layered electro-active nano-

polymersProject Guide:

Prof. Kajari KarguptaDept. Of Chemical Engineering

Jadavpur University

Dr. Saptarshi MajumdarDept. Of Chemical Engineering

Indian Institute Of Technology Hyderabad

Page 2: Development of optimally controlled drug release device using

Aim of the ProjectDevelopment of Smart Device : An

electro-active Polymer based drug delivery device

Page 3: Development of optimally controlled drug release device using

SIGNIFICANCE OF DRUG DELIVERY SYSTEM

Lower side effects Higher affectivity and higher bioavailability of

medicines closed to the affected portion of the body. Abandoned product

Multiple drugs in one shot

Lower required medical attention for patients

Page 4: Development of optimally controlled drug release device using

Commercial success can be found in following therapeutic categories:

Asthma Pain Management Cardiovascular Disease Dermatological Women’s Health

Medicines ApplicationsDexamethasone Neuro Inflammations

Dopamine NeurotransmitterSodium Salisylate Liver treatment

ATP Stimulator

Page 5: Development of optimally controlled drug release device using

CONDUCTING POLYMERS

An immobilizing medium that facilitate electron transfer as a result of the occurrence of an extensively delocalized -molecular orbital system in its structure

They exhibit the behavior of metals or semi-conductors (low excitation energy)

The random dispersion or aggregation of dopants in molar concentrations in the disordered chain like structure of polymers is called “Doping”

Low and intermediate stages of doping are observed as doping proceeds and polaron and bipolaron structures are formed.

Depending upon the various oxidation states they are classified into Emeraldine, Leucoemeraldine and Pernigraniline states(base or salt)

Page 6: Development of optimally controlled drug release device using

DIFFERENT OXIDATION STATES OF POLYANILINE

Only emeraldine (salt) is conductive

Page 7: Development of optimally controlled drug release device using

IMPORTANCE OF PANI AS A CONDUCTING POLYMERS

PANI having protonation, deprotonation and various other physico-chemical properties due to the presence of this -NH- group.

Inexpensive monomer, easy synthesis , environmental stability , simple doping by protonic acids .

PANI salt is quite stable and shows relatively high level of conductivity .

When treated with base the conducting PANI salt converts to the base form.

Electronic structure and electrical properties reversibly controlled by both oxidation and protonation .

Page 8: Development of optimally controlled drug release device using

OBJECTIVES :

Deposition of single and multi-layer thin film (electro-active polymer)

Studies on transport of ionic drug through polymeric film under applied time varying electric field.

Design a miniaturized capsule with a polymer membrane coating for the targeted and controlled release of anionic drugs essential for therapeutic activity.

Page 9: Development of optimally controlled drug release device using

Methodology:

Electrodeposition of conducting polymer membrane

=ELECTROCHEMICAL DEPOSITION: Two electrode system:

Cathode 25 mm Circular porous Stainless Steel plate(200 mesh)

Anode Graphite block

Sonication time(Ultra Sonicator: Piezo U Sonic):

2 hrs for PANI-p-TSA solution

30 minutes for PANI-p-TSA+ Dopant solution

Voltage: 30 volts,20 volts,10 volts (Voltage source: Testronics 92D)

Duration of electrodeposition: 1 hrs,2 hrs,4 hrs

Synthesis of conducting polymer :

Page 10: Development of optimally controlled drug release device using

ELECTRODEPOSITING SETUP

Testronics Voltage Source

Polymer membrane

Page 11: Development of optimally controlled drug release device using

Characterization of Conducting Polymer membrane

Scanning Electron Micrograph (SEM)

PANI(salt)-p-TSA

50 µm

100 µm

Page 12: Development of optimally controlled drug release device using

Transmission Electron Microscopy

PANI(base)-p-TSA

Page 13: Development of optimally controlled drug release device using

X-Ray Diffraction

0 10 20 30 40 50 60 700

100

200

300

400

500In

tens

ity(c

ps)

2 theta (degrees)

2d sin θ = n λ

Page 14: Development of optimally controlled drug release device using

Studies on transport of ionic drug through polymeric film under

applied time varying electric field.

Page 15: Development of optimally controlled drug release device using

Mechanism of Drug Release

Voltage (Positive Scan)

+

+

+

- +

- +

- +

-

-

-

Voltage (Negative Scan)

-

-

-

I

V

Porous BaseCP Film: Modified Working

Electrode

Counter Electrode

Permeate Side

Feed Side

Page 16: Development of optimally controlled drug release device using

Schematic Diagram of Experimental setup for Drug Release Study

DRUG RESERVOIR (A)

MEM

BR

AN

E

BODY FLUID (B)

PORO

US S

ILVE

R PL

ATE

L1=10cm

4cm

L2=5cm

2.5c

m

COMPUTER

RE

SAMPLE WITHDRAWING

A/D CONVERTER

4.290

OPENING SLOTWECE

meshGas cade

ONLINE pH and Conductivity measurement

PorousSilver plate

ID 2.5cm

OfflineUV-VIS

Spectrophotometer

Page 17: Development of optimally controlled drug release device using

Drug Delivery Experimental Set up

Page 18: Development of optimally controlled drug release device using

Platinum mesh (CE)Platinum mesh (CE)

COMPONENTS OF DRUG DELIVERY SET UPPolymer membrane(WE)

Gold thread (RE)

Page 19: Development of optimally controlled drug release device using

An electrode reaction refers to the net oxidation or reduction process that takes place at an electrode. This reaction may take place in a single electron-transfer step, or as a succession of two or more steps. The substances that receive and lose electrons are called the electroactive species

Three Electrode System

The major advantages of using a reference electrode are:

It is easy to prepare and maintain, and its potential is stable

During an electrode reaction involving a saturated solution of an insoluble salt of the ion, it helps in maintaining a fixed

concentration of an ionic species

Page 20: Development of optimally controlled drug release device using

Decrease of the effectiveness of the reference

electrode to stabilize working electrode voltage.

A resistance towards ion flow between the counter

and working electrodes, creating current dependent

voltage discrepancies due to IR drops

Disadvantages of Three Electrode System :

Page 21: Development of optimally controlled drug release device using

Type of Experimentations

1. Release characteristics from pre-loaded film (with drug) using a single compartment:

(i) In absence of feed solution

2. Experimentation on release characteristics using two compartment (feed and permeate side) module

(ii) OCP run: Study on diffusion characteristic with no applied voltage

(ii) Release due to Step potential

(iii) Release induced by Cyclic Voltammetry

Page 22: Development of optimally controlled drug release device using

Release pattern of para- toluene- sulfonic acid through Polyaniline (PANI) salt membrane in single compartment:

Details of experimentation for Polyaniline membrane: Membrane :

• PANI (salt) (24 mg) +NN-DMF(40 ml) sonicated for 2hr.• P-TSA as dopant (240 mg) sonicated for 30 mins .

Electro Deposition: Potential (V) = 30V

Duration=2hr Current Variation =0.09A

Drug Delivery Cell data:

Duration of experiment= 1hr We wanted to generate a step response in the cell

by giving the following target voltages and time in the Auto lab:

Voltage applied : -0.25V wrt RE

Page 23: Development of optimally controlled drug release device using

RESULT:

0 1000 2000 3000 4000 50000.00

0.02

0.04

0.06

0.08

0.10

Con

cent

ratio

n(M

)

Time(secs)

Source(V)

Time(sec)

-0.25 4500

In this case the concentration vs. time shows almost a linear profile which signifies the zero order release characteristics.

The average release rate estimated for PANI is 0.3 μmole/s

Page 24: Development of optimally controlled drug release device using

 Experimentation on release characteristics using two compartment (feed and permeate side) module.

Case Study I: Stability analysis of PANI –PTSA (OCP run)

• Open Circuit Potential: for 28hrs

• Deposition: 30 mg PANI salt +50 ml NN,DMF +300 mg pTSA 30 volts & 0.09 amps for 2 hrs. 

• Feed side: 0.1(M) PTSA solution.

• Permeate side: Water.

• Release due to Diffusion

Page 25: Development of optimally controlled drug release device using

Permeate side concentration (M) vs. Time (min)

Page 26: Development of optimally controlled drug release device using

CASE STUDY II: RELEASE CHARACTERISTICS OF PTSA AND SSA THROUGH PANI USING STEP VOLTAGE WRT RE

Details of experimentation for PTSA-PANI:

Membranei) PANI (salt) (30 mg) +NN-DMF(50 ml)

sonicated for 2hr. ii) P-TSA as dopant (300 mg)

sonicated for 30 mins.

Electro Deposition

Potential (V) = 30VDuration=2hr

Current Variation =0.08A 

Drug Delivery Cell dataDuration of experiment= 150min

 Open Circuit Potential: (for 600sec)

 Feed side: 0.1(M) P-TSA solution.Permeate side: Distilled Water.

Details of experimentation for SSA-PANI:

Membranei) PANI (salt) (80 mg) +NN-DMF(50 ml)

sonicated for 2hr. (ii)SSA as dopant (300 mg)

sonicated for 30 mins. 

Electro Deposition

Potential (V) = 30VDuration=2hr

Current Variation =0.08A 

Drug Delivery Cell dataDuration of experiment= 150min

 Open Circuit Potential: (for 600sec)

 Feed side: 0.1(M) SSA solution.Permeate side: Distilled Water.

Page 27: Development of optimally controlled drug release device using

Results of Step Voltammetry

Page 28: Development of optimally controlled drug release device using

Release characteristics of PTSA through PANI-salt membrane using Cyclic Voltammetry

Run OCP(Volt)

Conc. Of Feed(M)

Scan Rate(Volt/Sec)

Flux(mol/sec m2)

Leakage(mol)

4 -0.027 0.05 0.0001 1.099E-4 2.088E-51 -0.242 0.05 0.004 2.93E-5 5.814E-62 -0.330 0.05 0.005 2.589E-4 6.6E-63 -0.283 0.1 0.005 2.102E-4 3.034E-65 -0.294 0.15 0.005 1.132E-4 4.34E-6

Page 29: Development of optimally controlled drug release device using

Comparison Curve :

Page 30: Development of optimally controlled drug release device using

EFFECT ON FLUX AT DIFFERENT SCAN RATEScan Rate (0.0002v/s )

Scan Rate (0.002v/s)Scan Rate (0.004v/s )

Voltage

(v)

Flux

(mol/sec m2)

Voltage

(v)

Flux

(mol/sec m2)

Voltage

(v)

Flux

(mol/sec m2)

0

0.4

0.8

0.4

0

0

9.372E-5

3.8808E-4

0

0.176

0.434

0.8

0.61

0.4

0.23

0

0

2.7732E-3

2.465E-3

0

2.598E-5

1.996E-3

1.160E-3

0

0

0.553

0.393

0.153

0

1.75E-03

6.02E-05

6.63E-03

Page 31: Development of optimally controlled drug release device using

Comparison Curves:

Page 32: Development of optimally controlled drug release device using

Effect of Process Parameters on Molecular Release: An Exhaustive Search

Fig depicts the two bottlenecks identified using the model: leak during the forward cycle and retention at the end of the reverse cycle for varying voltage scan rate. Before elaborating the results of the exploration of the dynamics of ‘controlled molecular

release system’, let us first define the base cases (good and bad) of molecular release.

Page 33: Development of optimally controlled drug release device using

Recent Developments:-Similar experiments are now conducted by

using SSA doped PANI, and the bright side in such experiments is that the PANI-SSA is experimentally synthesized.

The Synthesized PANI-SSA serves as a potentially better source of such experimentation.

It will be not long before a miniaturized version of the experimental setup becomes scientifically viable.

Page 34: Development of optimally controlled drug release device using

Acknowledgements: I would like to convey my gratitude to the Department Of Biotechnology (DBT-INDIA) for

financially assisting the work.

My regards for Prof. Kajari Kargupta and Dr. Saptarshi Majumdar for their valuable and

expert guidance, keen interest, fruitful suggestions and unwavering encouragement

during the entire period of project work.

Finally I would like to specially thank Mr. Ajay Prodhan, the lab assistant without whom the

work would never have been completed.

Page 35: Development of optimally controlled drug release device using

Achievements :

Morphological Studies (TEM) show a connected nano -particle like structure of the polymer membrane(<50 nm)

Prediction of release pattern

A protocol for different time scan and different release pattern is obtained for different experimentation

Drawbacks :

Mechanical leakage : Teflon – metal joints : modifications of design

Membrane stability crucially depends on the parameters of electro-deposition : leakage in membrane

Oxidation of the membrane due to exposure with the environment

Conclusions:

Page 36: Development of optimally controlled drug release device using